These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31115494)

  • 21. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
    Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
    Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
    World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein/Hippo signaling pathway.
    Li T; Li Y
    Immunobiology; 2023 Mar; 228(2):152324. PubMed ID: 36608594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Keratin 6A gene silencing suppresses cell invasion and metastasis of nasopharyngeal carcinoma via the β‑catenin cascade.
    Chen C; Shan H
    Mol Med Rep; 2019 May; 19(5):3477-3484. PubMed ID: 30896882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. URG4-silencing suppresses cell proliferation in nasopharyngeal carcinoma through induction of apoptosis.
    Luo XY; Yan B; Cai CF; Chen AM; Zhou M
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1717-1725. PubMed ID: 29630117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simvastatin induces apoptosis of nasopharyngeal carcinoma cells through NF-κB signaling pathway.
    Sun FR; Wang SL; Wang M; Sun LM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6726-6734. PubMed ID: 32633363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ARNTL hypermethylation promotes tumorigenesis and inhibits cisplatin sensitivity by activating CDK5 transcription in nasopharyngeal carcinoma.
    Peng H; Zhang J; Zhang PP; Chen L; Tang LL; Yang XJ; He QM; Wen X; Sun Y; Liu N; Li YQ; Ma J
    J Exp Clin Cancer Res; 2019 Jan; 38(1):11. PubMed ID: 30621723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of Sp1 suppresses cell proliferation, clonogenicity and the expressions of stem cell markers in nasopharyngeal carcinoma.
    Zhang JP; Zhang H; Wang HB; Li YX; Liu GH; Xing S; Li MZ; Zeng MS
    J Transl Med; 2014 Aug; 12():222. PubMed ID: 25099028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin reverses the drug resistance of cisplatin in irradiated CNE-1 human nasopharyngeal carcinoma cells through PECAM-1 mediated MRPs down-regulation.
    Sun Y; Chen X; Zhou Y; Qiu S; Wu Y; Xie M; Zhu G; Liang S; Li H; Zhou D; Ju Z; Wang F; Han F; Wang Z; Wang R
    Int J Med Sci; 2020; 17(16):2416-2426. PubMed ID: 33029084
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo.
    Huang Y; Tian Y; Zhao Y; Xue C; Zhan J; Liu L; He X; Zhang L
    Cancer Commun (Lond); 2018 May; 38(1):15. PubMed ID: 29764490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gemcitabine synergizes with cisplatin to inhibit nasopharyngeal carcinoma cell proliferation and tumor growth.
    He SW; Zhang Y; Chen L; Luo WJ; Li XM; Chen Y; Huang SY; He QM; Yang XJ; Li YQ; Liu N; Zhao Y; Ma J
    FASEB J; 2021 Oct; 35(10):e21885. PubMed ID: 34478585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDC25A inhibition suppresses cell proliferation and induces G
    Wang B; Gong Q; Chen F
    Mol Med Rep; 2023 May; 27(5):. PubMed ID: 37052240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ARC is highly expressed in nasopharyngeal carcinoma and confers X-radiation and cisplatin resistance.
    Wu P; Tang Y; He J; Qi L; Jiang W; Zhao S
    Oncol Rep; 2013 Oct; 30(4):1807-13. PubMed ID: 23877130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma.
    Wang Y; Wang Y; Fan X; Song J; Wu H; Han J; Lu L; Weng X; Nie G
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1214-1220. PubMed ID: 30017199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.
    Su Z; Li G; Liu C; Ren S; Tian Y; Liu Y; Qiu Y
    Oncol Rep; 2016 Jul; 36(1):72-8. PubMed ID: 27108809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deuterium-depleted water (DDW) inhibits the proliferation and migration of nasopharyngeal carcinoma cells in vitro.
    Wang H; Zhu B; He Z; Fu H; Dai Z; Huang G; Li B; Qin D; Zhang X; Tian L; Fang W; Yang H
    Biomed Pharmacother; 2013 Jul; 67(6):489-96. PubMed ID: 23773852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1.
    Su H; Liu L; Zhang Y; Wang J; Zhao Y
    Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.